InsidersTradesSigma
바이오니아 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 바이오니아 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 바이오니아 has published 61 public disclosures. The latest transaction was filed on 4 February 2026 (Other). Among the most active insiders: 이중열. The full history is free.
61
Insider Decl.
n/a
Thresholds
n/a
20 ops.
Buy Volume
n/a
1 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 4 February 2026
Declarations61 total
25 of 61 declarations
About 바이오니아
BioNia is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development of biopharmaceutical solutions.